Eli Lilly and Company announced that its chemotherapy ALIMTA (pemetrexed for injection) received a positive "Final Appraisal Determination" from the United Kingdom's National Institute for Health and Clinical Excellence.
Pearl Therapeutics Inc. announced positive results from a Phase 1 safety and pharmacokinetics study of PT003, its lead combination therapeutic for the treatment of chronic obstructive pulmonary disease (COPD).
Name a human gene, and you’ll find a movie online showing you what happens to cells when it is switched off. This is the resource that researchers at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, and their collaborators in the Mitocheck consortium are making freely available.
Eli Lilly and Company announced that the U.S. District Court for the Southern District of Indiana has upheld the validity of the company's compound patent on Gemzar.
Pfizer Inc. paid doctors and teaching hospitals a total of $35 million in the last half of 2009 for services ranging from speaking to other doctors about the company's products to running studies of its experimental drugs.
Full results of a big study testing a drug for preventing prostate cancer show a higher risk of heart failure, a surprise finding that could dampen enthusiasm for expanding its use.
Sanofi-Aventis has settled three patent infringement lawsuits in the U.S. related to generic versions of colon cancer treatment Eloxatin, the French drug maker said.
Growth in U.S. sales of pharmaceuticals bounced back last year as rebates and low-cost generic drugs drove an increase in the number of prescriptions filled, according to data tracking firm IMS Health.
The Evolve EMCCD camera from Photometrics, a designer and manufacturer of high-performance CCD and EMCCD cameras for the life sciences, was ranked fourth among The Scientist’s “Top 10 Innovations of 2009.”
Lumigen HyPerBlu, a novel chemiluminescent substrate from Beckman Coulter, Inc., enables direct detection of hydrogen peroxide.
Thermo Fisher Scientific Inc. and biopharmaceutical company Eli Lilly and Company announced that they have expanded their clinical trial materials supply chain relationship.
Keyrus Biopharma, a contract research organization operating in Europe and part of the Keyrus Group, has standardized on Oracle Clinical and Oracle Database to help increase efficiency in clinical trial data collection, improve data quality and security, and support the organization’s European expansion plans.
Hatchtech Pty Ltd confirms a successful Phase 2a clinical trial evaluating DeOvo, an investigational proprietary drug being developed as a new topical treatment for head lice infestation.
The US Food and Drug Administration has given clearance to Melbourne’s Clinuvel Pharmaceuticals to commence a Phase 2 study of its drug, afamelanotide, in up to 60 patients diagnosed with the rare light intolerance erythropoietic protoporphyria (EPP).
In gastric cancer patients who have had part or all of their stomach removed, the hormone ghrelin may lessen post-operative weight loss and improve appetite, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute.